South-Eastern Asia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in South-Eastern Asia

In 2022, the Southeast Asian medicaments containing hormones market decreased by X% to $X, falling for the second year in a row after two years of growth. The total consumption indicated a resilient expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Medicaments Containing Hormones Production in South-Eastern Asia

In value terms, medicaments containing hormones production amounted to $X in 2022 estimated in export price. The total production indicated a prominent expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The most prominent rate of growth was recorded in 2014 when the production volume increased by X%. The level of production peaked at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports in South-Eastern Asia

In 2022, after two years of growth, there was decline in overseas shipments of medicaments containing hormones but not antibiotics, when their volume decreased by X% to X tons. Overall, exports, however, showed a significant expansion. The pace of growth appeared the most rapid in 2015 when exports increased by X%. The volume of export peaked at X tons in 2021, and then shrank modestly in the following year.

In value terms, medicaments containing hormones exports shrank modestly to $X in 2022. In general, exports, however, continue to indicate a resilient expansion. The growth pace was the most rapid in 2015 with an increase of X% against the previous year. Over the period under review, the exports hit record highs at $X in 2021, and then shrank slightly in the following year.

Exports by Country

The biggest shipments were from Indonesia (X tons), together amounting to X% of total export.

Indonesia was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2022. While the share of Indonesia (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Indonesia ($X) also remains the largest medicaments containing hormones supplier in South-Eastern Asia.

In Indonesia, medicaments containing hormones exports increased at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in South-Eastern Asia amounted to $X per ton, flattening at the previous year. Overall, the export price continues to indicate a deep contraction. The most prominent rate of growth was recorded in 2019 an increase of X% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Indonesia.

From 2012 to 2022, the rate of growth in terms of prices for Indonesia amounted to X% per year.

Medicaments Containing Hormones Imports

Imports in South-Eastern Asia

Medicaments containing hormones imports contracted modestly to X tons in 2022, which is down by X% compared with the previous year. Over the period under review, imports showed a relatively flat trend pattern. The growth pace was the most rapid in 2016 with an increase of X%. As a result, imports attained the peak of X tons. From 2017 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing hormones imports reduced notably to $X in 2022. Overall, imports showed a perceptible decrease. The pace of growth appeared the most rapid in 2013 with an increase of X%. As a result, imports attained the peak of $X. From 2014 to 2022, the growth of imports remained at a lower figure.

Imports by Country

Malaysia (X tons) and Myanmar (X tons) dominates imports structure, together constituting X% of total imports. It was distantly followed by Singapore (X tons), committing an X% share of total imports. Vietnam (X tons), Indonesia (X tons) and the Philippines (X tons) took a relatively small share of total imports.

From 2012 to 2022, the biggest increases were recorded for Singapore (with a CAGR of X%), while purchases for the other leaders experienced mixed trends in the imports figures.

In value terms, the largest medicaments containing hormones importing markets in South-Eastern Asia were Malaysia ($X), Singapore ($X) and Myanmar ($X), with a combined X% share of total imports.

Singapore, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced mixed trends in the imports figures.

Import Prices by Country

The import price in South-Eastern Asia stood at $X per ton in 2022, waning by X% against the previous year. In general, the import price showed a noticeable decline. The growth pace was the most rapid in 2017 when the import price increased by X% against the previous year. Over the period under review, import prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Singapore ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Myanmar (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :